Skip to main content
. 2012 Mar 19;7(3):e31869. doi: 10.1371/journal.pone.0031869

Figure 5. Comparison of chemical structures and IC50 values of analogs demonstrating improved bioactivity as Aβ oligomerization inhibitors.

Figure 5

Compound 2 represents an improvement of approximately 6–7 fold over Aβ aggregation inhibitory activity of curcumin.